Aclara Receives Positive Environmental Qualification Resolution For The Penco Module

Aclara Receives Approval of Environmental Impact Assessment in Chile

Aclara Receives Favourable Consolidated Evaluation Report to the Penco Module Environmental Assessment Process

Aclara Announces Results from Technical Reports on Its Integrated Heavy Rare Earths Supply Chain

Aclara Announces Filing and Results of Feasibility Study for Its Flagship Carina Project

Aclara Submits Final Addendum to the Penco Module Environmental Impact Assessment

Aclara Inaugurates Rare Earth Separation Pilot Plant in Virginia Tech to Advance U.S. Supply of Heavy Rare Earths

Aclara Announces Significant Progress in Its Metals and Alloys Project

Aclara and Argonne National Laboratory Partner to Develop AI-Enabled Digital Twin for Heavy Rare Earth Separation

CEO Letter to Aclara Shareholders: 2025 Accomplishments and 2026 Outlook

Aclara and Vac Strengthen Mine-To-Magnet Collaboration During Visit to Aclara's Pilot Plant in Brazil

Aclara Announces Filing and Results of Pre-Feasibility Study for Its Flagship Carina Project

Aclara To Build First Heavy Rare Earths Separation Facility in U.S. With a Secured Sustainable Ionic Clay Feed by Mid-2028

Aclara Enters the Final Stages of the Permitting Process for the Penco Module

American Renal Associates Holdings Inc (NYSE:ARA) Sees Significant Decline in Short Interest

Short Interest in American Renal Associates Holdings Inc (NYSE:ARA) Declines By 5.3%

American Renal Associates (NYSE:ARA) Shares Up 14.3%

American Renal Associates Holdings Inc (NYSE:ARA) Short Interest Down 10.8% in March

Brokerages Expect American Renal Associates Holdings Inc (NYSE:ARA) Will Announce Quarterly Sales of $201.73 Million

American Renal Associates Holdings Inc (NYSE:ARA) Expected to Announce Earnings of -$0.29 Per Share

American Renal Associates Holdings Inc (NYSE:ARA) Shares Purchased by Citigroup Inc.

American Renal Associates Holdings Inc (NYSE:ARA) Short Interest Update

Zacks: Brokerages Anticipate American Renal Associates Holdings Inc (NYSE:ARA) Will Announce Quarterly Sales of $201.73 Million

Zacks: Analysts Anticipate American Renal Associates Holdings Inc (NYSE:ARA) Will Post Earnings of -$0.29 Per Share

American Renal Associates (NYSE:ARA) Stock Price Up 9.8% Following Better-Than-Expected Earnings

ValuEngine Lowers American Renal Associates (NYSE:ARA) to Hold

American Renal Associates : Q4 Earnings Presentation | MarketScreener

American Renal Associates (ARA) Set to Announce Quarterly Earnings on Monday

Analyzing Pacific Health Care Organization (OTCMKTS:PFHOD) and American Renal Associates (OTCMKTS:ARA)

American Renal Associates Holdings Inc (NYSE:ARA) Expected to Post Quarterly Sales of $217.42 Million